Medical Optimization & Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD)

This is a randomized double-blind clinical trial of insulin plus placebo versus insulin plus metformin for the treatment of overt T2DM complicating pregnancy. Women will be randomized between 10 weeks 0 days and 20 weeks 6 days gestation and followed until 30 days after delivery. Neonate outcomes will be followed until 30 days of age. Women will have the option to enroll into the dyad registry, this will follow them up to 10 years to update their contact information in case any new funding becomes available for future research.

You may be eligible for this study if you meet the following criteria:

• Conditions: TBD, tbd, tbd
• Age: 99 years or below
• Gender: All